Improving genomic‐informed risk assessments for dementia by combining modifiable risk factors and polygenic scores in the All of Us Research Program

Abstract

Background: Genomic‐informed risk assessments have the potential to improve patient outcomes for dementia through risk‐stratification and prediction of treatment‐response.